There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

His areas of research interest include the psychiatric and cognitive complications of Parkinson's disease ... history of an ICD before PD onset, and dopamine agonist therapy-have been found ...

A year after administration of a mesencephalon dopamine nerve cell therapy derived from embryonic stem cells, it was ...

Understanding how human neurons cope with the energy demands of a large, active brain could open up new avenues for treating ...

A so-called “happy” neurotransmitter, dopamine is involved in memory, mood, motivation, and movement. Dopamine plays a key role in several medical conditions like Parkinson’s disease, fibromyalgia, ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

24, 2024 — Parkinson's disease, a debilitating nervous system ... neurological disorders attributed to dysfunctions in specific dopamine ... Alzheimer's Drug May Slow Down Cognitive Decline ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

That's why lack of dopamine causes the slowed movements and tremors symptoms of Parkinson's disease," the Cleveland Clinic reports. As the disease progresses, these symptoms intensify. Parkinson's ...